Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04859296 · ClinicalTrials.gov registry record · Phase 1

AnalgeSiC and appEtite-stimulating Effects of caNnabigerol and THC (ASCENT)

A Phase 1 study of Pain and Abuse, Drug, sponsored by University of California, Los Angeles.

Active
Registry status
Phase 1
Development phase
20
Enrollment target
1
Study location

NCT04859296 is a Phase 1 study of Pain and Abuse, Drug that is active but no longer recruiting, run by University of California, Los Angeles. The registered enrollment target is 20 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04859296, a Phase 1 study of Pain and Abuse, Drug, is active but no longer recruiting, sponsored by University of California, Los Angeles.

ACTIVE NOT RECRUITING
Registry status
Phase 1
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

This study will assess the analgesic, appetite-stimulating, and subjective effects of cannabigerol (CBG) alone and in combination with THC.

Conditions Studied

Pain Abuse, Drug Appetite Loss

Interventions

  • DRUG Placebo
  • DRUG Low THC
  • DRUG High THC
  • DRUG Low CBG
  • DRUG High CBG

Study Locations (1)

California

  • University of California, Los Angeles - Los Angeles

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2023-02-15
Est. Completion 2026-12-04
Phase Phase 1

Sponsor

University of California, Los Angeles

897 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04859296

The ClinicalTrials.gov registry entry for NCT04859296 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (93% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Pain appearing as the primary indexed condition, and to 5 interventions - of which Placebo is the first listed.

NCT04859296 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04859296 about?

NCT04859296 is a clinical study titled "AnalgeSiC and appEtite-stimulating Effects of caNnabigerol and THC (ASCENT)". This study will assess the analgesic, appetite-stimulating, and subjective effects of cannabigerol (CBG) alone and in combination with THC.

What is the current status of trial NCT04859296?

This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2023-02-15. Estimated completion is 2026-12-04.

What conditions does trial NCT04859296 study?

This clinical trial studies the following conditions: Pain, Abuse, Drug, Appetite Loss.

What interventions are being tested in trial NCT04859296?

The interventions under investigation include: Placebo (DRUG), Low THC (DRUG), High THC (DRUG), Low CBG (DRUG), High CBG (DRUG).

Who is sponsoring clinical trial NCT04859296?

This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04859296 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Pain

All registered trials for this condition

Abuse, Drug

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.